Selank 5 mg

Selank is a synthetic heptapeptide derived from the sequence of the endogenous tetrapeptide tuftsin and extended with a stabilising tripeptide fragment. This defined structure means Selank is also described as a tuftsin analogue in research contexts.

The Selank research peptide is referenced in in-vitro laboratory literature in areas including peptide characterisation, receptor-binding assay development, stability studies and comparative synthetic peptide chemistry.

The Selank research compound is being prepared as a 5 mg research-use-only laboratory material. Once batch release is complete, it will be supplied as a white lyophilised powder in a sterile amber vial, with batch-specific documentation available for verification.

Batch release, HPLC certification and independent third-party testing are currently in progress. Selank is therefore not yet available to buy, and the stated 99%+ purity should not be presented as a completed batch result until certification and testing have been finalised.

Selank is not a medicine, supplement or veterinary product, is not licensed by the MHRA for human or animal use, and must not be administered to humans or animals.

NXT GEN RESEARCH is a UK supplier preparing Selank for laboratory research. The planned Selank 5 mg product will be stocked and dispatched from within the United Kingdom following completion of the stated batch release process.

Once available, UK orders are intended to be sent using the stated 24-hour tracked service, with delivery listed as 1-3 business days. Pricing is shown in GBP, and institutional buyers can use the institutional account route where invoicing is required.

NXT GEN RESEARCH acts as the product provider and supplier rather than a research contractor. The service covers the supply of research material and its supporting documentation once released. The design and conduct of laboratory research remain outside the product supply service.

Researchers can register an email address online now to receive a notification once the current Selank batch has completed the release process and becomes available.

Researchers comparing a Selank provider or supplier should be able to assess the material using its specification and completed batch documentation rather than relying solely on broad descriptions such as ‘trusted’, ‘reliable’ or ‘affordable’.

For this product, the stated specification includes a target purity of 99%+, a defined batch reference and planned HPLC certification and independent third-party testing for identity and purity. However, the current product information states that these release processes are still in progress.

This distinction is important when assessing laboratory grade Selank. The material should only be described using completed batch-testing results once those results and the corresponding Certificate of Analysis are available.

The planned 5 mg product contains Selank lyophilised powder supplied in a sterile amber vial. The product specification identifies the material as a synthetic heptapeptide derived from the tuftsin sequence.

Once released, each vial will carry its batch code so the physical research material can be matched with its corresponding batch documentation.

Researchers searching specifically for Selank 5mg can register for an availability notification while batch release, HPLC certification and independent third-party testing are completed.

The planned Selank 5mg product contains 5 mg of synthetic research peptide in a sterile amber vial. The material is specified as a white lyophilised powder and classified as a synthetic heptapeptide.

Batch SEL-2608-015 is currently undergoing the stated release, HPLC certification and third-party testing processes. The product should not be treated as available stock until these processes have been completed and its availability status has been updated.

Selank is intended to be available online from NXT GEN RESEARCH exclusively for scientific and laboratory research, but the current 5 mg product has not yet been released for sale.

Laboratories looking to buy Selank online in the UK can currently register for an availability notification rather than place an order. This keeps the distinction clear between a forthcoming ‘Selank for sale’ listing and material that has completed batch release and is ready for laboratory supply.

The listed price is £29.99 for 5 mg. Once released, this published price will allow laboratories to assess whether the product is affordable for their purchasing requirements alongside the completed specification and batch documentation.

For researchers looking for Laboratory Grade Selank, the specification and completed batch documentation provide a more meaningful basis for assessment than the term alone.

The proposed product specification states 99%+ purity, with HPLC certification and independent third-party testing for identity and purity. These processes are currently in progress for batch SEL-2608-015.

Once the batch has completed release, its documentation can provide the evidence researchers need to assess the material before ordering.